Although such comprehensive approaches extend beyond the present work, our current findings establish a solid foundation—particularly the FBXW7-mediated axis—for subsequent high-resolution studies into the miR-32-5p/c-MYC regulatory network in breast cancer. The gene discussed is MYC; the disease is breast carcinoma.